How to Buy Integra Lifesciences Holdings Stock
Integra Lifesciences Holdings Corp
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery.
Integra Lifesciences Holdings stock last closed at $22.01, up 0.87% from the previous day, and has decreased 36.81% in one year. It has underperformed other stocks in the Medical Devices industry by 0.17 percentage points. Integra Lifesciences Holdings stock is currently +30.97% from its 52-week low of $16.81, and -37.91% from its 52-week high of $35.45.
As of Mar 27, 2025, there are 77.22M shares of IART outstanding. The market cap of IART is $1.70B. In the past 24 hours, 401,044 IART shares were traded.
How to Buy Integra Lifesciences Holdings Stock
Not sure how to invest in Integra Lifesciences Holdings stock? Here's how.
- Figure out where to buy Integra Lifesciences Holdings stock: You need to pick an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Integra Lifesciences Holdings stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your info.
- Research Integra Lifesciences Holdings stock: The Integra Lifesciences Holdings ticker symbol is IART. Is Integra Lifesciences Holdings stock a good investment? Should you buy shares of IART? How do IART's underlying business fundamentals look? Do top analysts think Integra Lifesciences Holdings is a good buy? Why has IART's stock price moved recently? (Hint: Our stock research tools can help you figure out if IART is a good stock to buy).
- Execute your IART buy order: Decide if you will purchase IART shares at the current market price or use a limit order to buy IART shares at a particular price.
- Monitor your IART position: Create a watchlist to watch your position in Integra Lifesciences Holdings stock.
Step 1: Figure out where to buy Integra Lifesciences Holdings stock
You need a brokerage account to access the NASDAQ market and buy IART shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to invest in IART today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create your new trading account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on one of the most highly reviewed stock trading apps, you need to deposit funds:
Check out the video below if you need help transferring funds into your new investment account.
Step 4: Research Integra Lifesciences Holdings stock
Once you have chosen the best place to buy Integra Lifesciences Holdings stock, it's important to analyze their stock prior to buying, so you truly wrap your head around the risk and opportunity.
Overview of key IART info
IART Overview
WallStreetZen was created to help average investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on IART's stock page.
Is IART stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge IART's intrinsic value.
Using relative valuations metrics:
- IART may be undervalued based on its P/B ratio of 1.1x, relative to Medical Devices industry P/B ratio of 3.97x
You can access more valuation analysis on IART's stock here.
IART Financial Health Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the IART balance sheet.
Failed Financial Due Diligence Checks:
- IART profit margin has gone down from 4.4% to -0.4% in the past year.
- IART earnings of $52.40M is not sufficient to cover its interest payments.
- There are more long-term liabilities than short-term assets on the IART balance sheet.
- IART has a relatively high debt to equity ratio of 1.61.
- Total IART debt is higher than 5 years ago, relative to shareholder equity.
- IART's operating cash flow of $129.38M allows it to safely service it's debt of $1.98B.
Is IART stock a Buy, Hold, or Sell, according to analysts?
Out of 4 sell side analysts who give ratings on IART, the consensus analyst rating on IART is a Sell
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Integra Lifesciences Holdings stock forecast page.
IART Technicals
IART Earnings
Last year, IART revenue was $1.61B. In the past 5 year, IART's revenue has gone up by 1.2% per year. This was slower than the Medical Devices industry average of 9.99%.
Dig into IART's earnings and revenue performance here.
Latest Insiders Trades at IART
In the last year, insiders at IART have bought more shares than they have sold.
Robert T. Davis Jr., EVP President TT of IART, was the latest IART insider to sell. They sold $11,304.40 worth of IART stock on Mar 11, 2025.
Learn more about who owns IART stock here.
Can I rely on IART as an income stream?
No, Integra Lifesciences Holdings doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your IART buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount limit, place a limit order.
Press the Open button and your broker will place the order.
If you need additional info about buying stocks on eToro, click the how to video below:
Step 6: Monitor your IART position
Now that you own some IART stock, you'll want to keep up with your new shares.
Put IART on a watchlist to get the latest updates about your IART stock.
IART Feed
How to Buy Stock in Integra Lifesciences Holdings
To reiterate, here are the 6 steps to buy stock in Integra Lifesciences Holdings:
- Figure out where to buy Integra Lifesciences Holdings stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Research Integra Lifesciences Holdings stock
- Execute your IART buy order
- Monitor your IART position
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your investment in Integra Lifesciences Holdings, get started below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.